Richard Daniell

Richard Daniell

Executive Vice President, European CommercialatTeva Pharmaceutical Industries· In proxies 2023–2024

Pay in FY2024+5% from the year before

Richard Daniell was paid $5.4M in FY2024 (Dec), up 5%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Teva Pharmaceutical Industries proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Teva Pharmaceutical IndustriesPublic company · 3 yr
    • Executive Vice President, European Commercial2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?